A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

December 12, 2023

Study Completion Date

December 12, 2023

Conditions
Cancer, Hepatocellular
Interventions
DRUG

nivolumab

Specified dose on specified days

DRUG

ipilimumab

Specified dose on specified days

PROCEDURE

TACE

TACE (Trans-arterial ChemoEmbolization)

Trial Locations (107)

0

Local Institution - 0004, Hong Kong

Local Institution - 0045, Hong Kong

613

Local Institution - 0136, Buzi

704

Local Institution - 0029, Tainan City

807

Local Institution - 0141, Kaohsiung City

1070

Local Institution - 0050, Plainfield

1090

Local Institution - 0078, West Springfield

1100

Local Institution, Vienna

1200

Local Institution - 0020, Brussels

2500

Local Institution, Wollongong

2700

Local Institution - 0048, Wiener Neustadt

3065

Local Institution - 0001, Melbourne

3100

Local Institution - 0013, Sankt Pölten

4103

Local Institution - 0071, Leipzig

4575

Local Institution - 0037, Birtinya

5000

Local Institution - 0010, Adelaide

6150

Local Institution - 0139, Murdoch

6202

Local Institution - 0012, Nice

8036

Local Institution - 0026, Graz

8208

Local Institution - 0131, Sabadell

9000

Local Institution - 0053, Ghent

9042

Local Institution, Monserrato

10002

Local Institution - 0002, Taipei

10043

Local Institution - 0015, Orbassano

11217

Local Institution - 0044, Tapei

13285

Local Institution - 0061, Marseil

14004

Local Institution - 0092, Córdoba

14033

Local Institution - 0132, Caen

15000

Local Institution, Prague

15706

Local Institution - 0102, Santiago de Compostela

20007

Local Institution, Washington D.C.

20122

Local Institution - 0025, Milan

21000

Local Institution - 0064, Dijon

28007

Local Institution - 0101, Madrid

28027

Local Institution - 0183, Madrid

28034

Local Institution - 0084, Madrid

28041

Local Institution - 0018, Madrid

30625

Local Institution, Hanover

31008

Local Institution - 0099, Pamplona

34295

Local Institution - 0082, Englewood

36100

Local Institution - 0070, Vicenza

37075

Local Institution - 0035, Göttingen

38700

Local Institution - 0052, La Tronche

40202

Local Institution - 0005, Louisville

40217

Local Institution - 0059, Louisville

40447

Local Institution - 0030, Taichung

40705

Local Institution - 0057, Taichung

41944

Local Institution - 0135, Daegu

43126

Local Institution, Parma

44093

Local Institution - 0087, Nantes

49241

Local Institution - 0114, Busan

51092

Local Institution - 0046, Reims

53100

Local Institution - 0076, Siena

58128

Local Institution - 0097, Hwasun-Gun

59037

Local Institution - 0014, Lille

69120

Local Institution, Heidelberg

75013

Local Institution - 0093, Paris

75203

Local Institution - 0109, Dallas

78584

Local Institution, Roma

92110

Local Institution - 0021, Clichy

92118

Local Institution - 0189, Coronado

94805

Local Institution - 0094, Villejuif

98124

Local Institution, Messina

100034

Local Institution - 0184, Beijing

110042

Local Institution, Shenyang

119074

Local Institution - 0027, Singapore

197758

Local Institution - 0077, Saint Petersburg

198255

Local Institution - 0009, Saint Petersburg

200040

Local Institution - 0151, Shanghai

210009

Local Institution - 0196, Nanjing

217562

Local Institution - 0089, Singapore

300060

Local Institution, Tianjin

308433

Local Institution - 0011, Singapore

310003

Local Institution, Hangzhou

310022

Local Institution, Hangzhou

330006

Local Institution - 0176, Nanchang

510060

Local Institution, Guangzhou

510095

Local Institution, Guangzhou

610041

Local Institution, Chengdu

656049

Local Institution - 0016, Barnaul

710100

Local Institution - 0209, Xi'an

2320024

Local Institution - 0120, Yokohama

4102295

Local Institution - 0125, Izunokuni-Shi

9208641

Local Institution - 0118, Kanazawa

72115700

Local Institution, Federal District

G1R 2J6

Local Institution - 0039, Québec

779 00

Local Institution - 0055, Olomouc

260-8677

Local Institution - 0108, Chiba

790-0024

Local Institution - 0122, Matsuyama

060-0033

Local Institution - 0148, Sapporo

241-0815

Local Institution - 0113, Yokohama

602-0841

Local Institution - 0115, Kyoto

545-8586

Local Institution - 0127, Abeno-ku

105-8470

Local Institution - 0116, Minato-ku

Local Institution - 0128, Minato-ku

180-8610

Local Institution - 0121, Musashino-shi

734-8551

Local Institution - 0119, Hiroshima

589-8511

Local Institution - 0117, Osaka

350-0495

Local Institution - 0123, Saitama

02-034

Local Institution, Warsaw

00902

Local Institution - 0049, San Juan

050612

Local Institution - 0047, Gyeongsangnam-do

03080

Local Institution - 0161, Seoul

05505

Local Institution - 0186, Seoul

06351

Local Institution - 0160, Seoul

120-752

Local Institution - 0164, Seoul

03010

Local Institution - 0023, Alicante

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY